- Executive in Residence
Benjamin Pless has over 25 years of experience developing and bringing to market implantable medical devices. As an Executive in Residence at Mass General Brigham Innovation, Mr. Pless works with clinicians to convert clinical observations into inventions, develop IP, and help spin-off companies. Prior to joining Mass General Brigham he was CEO of Autonomic Technologies, developing a minimally invasive neurostimulator to treat severe headache. Prior to that he was the Chief Operating Officer and Chief Technical Officer of NeuroPace, a privately-held company developing electronic implantable devices for the treatment of epilepsy. Before joining NeuroPace in 2000, he was responsible for worldwide development activities for the Cardiac Rhythm Management Division of St. Jude Medical, Inc. Mr. Pless previously served as Vice President of product development for Ventritex, Inc. and General Manager of its Maven Capacitors division until the sale of the company to St. Jude Medical in 1997. His career began at Intermedics, where he was a development engineer for implantable pacemakers.
Mr. Pless is a member of the board of directors of several start-up medical device companies and regularly provides consulting services to the venture capital community. Mr. Pless received a B.S.E.E. from the Massachusetts Institute of Technology and was a PhD candidate at Rice University. He is a named inventor on over 140 US patents.